Regenesome Inc.
PrivateLast Round
Pre Seed
Aug 1, 2025
Total Funding Raised
$880,000
Company Overview
Regenesome Inc. is a biotechnology company that develops anti-aging technology intended for supplements, foods and cosmetics that utilize exosomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Space Technology, Fashion & Beauty
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenesome Inc. Comps
Public and private peers based on sector, stage, and business model.
Regenesome Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Aug 1, 2025 | ||||
| Debt | May 1, 2025 | ||||
| Pre Seed | Oct 21, 2024 |
Regenesome Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leave a Nest Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Monthly visitors increased 87% MoM.
- Dec 9, 2025
Monthly visitors increased 1318% MoM, from 68 to 964.
Regenesome Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Regenesome Inc.'s valuation, stock price, and market status.
